Kayne Anderson Rudnick Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q3
Sell
-27,879
Closed -$1.76M 328
2015
Q2
$1.76M Hold
27,879
0.03% 224
2015
Q1
$1.34M Hold
27,879
0.02% 235
2014
Q4
$925K Hold
27,879
0.02% 253
2014
Q3
$817K Hold
27,879
0.01% 255
2014
Q2
$1.08M Buy
+27,879
New +$1.08M 0.02% 239